JYMed yakhazikitsa dongosolo lolimba la kasamalidwe kabwino, ndikupeza ziphaso zitatu zoperekera zinthu ndi ntchito zomwe zimakwaniritsa miyezo yapadziko lonse lapansi.

Pomwe ikuyesetsa kupeza phindu pazachuma, kampaniyo yakhala ikutsatira malamulo ndi malamulo oteteza chilengedwe. Kukwanilitsidwa kwa satifiketi ya ISO 14001 kukuwonetsa kudzipereka kwa JYMed Peptide pachitukuko chokhazikika, kukhazikitsa njira zosamalira zachilengedwe, komanso kukwaniritsa udindo wake wokhudzana ndi chikhalidwe cha anthu monga bizinesi yaukadaulo wapamwamba mubizinesi yazachilengedwe.

Thanzi ndi chitetezo cha ogwira ntchito ndizofunika kwambiri pa JYMed Peptide. Kuchokera pakuwunika zoopsa kupita ku kukonza malo, kuchokera ku maphunziro a ogwira ntchito kupita ku machitidwe oyankha mwadzidzidzi, kampaniyo imatsimikizira kuti wogwira ntchito aliyense akhoza kugwira ntchito pamalo otetezeka komanso athanzi. Kupezedwa kwaposachedwa kwa satifiketi ya ISO 45001 kukuwonetsa kulemekeza kwa JYMed Peptide pa kufunikira kwa moyo ndipo zikuwonetsa kuti kampaniyo yafika pamlingo wapamwamba padziko lonse lapansi pakuwongolera zaumoyo ndi chitetezo pantchito.

Za JYMed

JYMed ndi kampani yopanga zamankhwala yapamwamba kwambiri yomwe imayang'ana pa kafukufuku wodziyimira pawokha, chitukuko, kupanga, ndi malonda azinthu zopangidwa ndi peptide. Timaperekanso ntchito zambiri za CDMO, kupereka mayankho a peptide makonda kwamakasitomala azachipatala padziko lonse lapansi, zodzoladzola, ndi zanyama.

Zogulitsa zathu zikuphatikiza ma API angapo a peptide, okhala ndi zinthu zoyambira monga Semaglutide ndi Terlipressin atamaliza bwino zolemba za US FDA DMF.

Kampani yathu yocheperako, Hubei JXBio Pharmaceutical Co., Ltd., imagwiritsa ntchito njira zamakono zopangira peptide API yomangidwa kuti ikwaniritse miyezo ya cGMP yokhazikitsidwa ndi US FDA, ndi NMPA yaku China. Malowa amakhala ndi mizere 10 yayikulu komanso yoyendetsa ndege, mothandizidwa ndi dongosolo lolimba la pharmaceutical quality management system (QMS) komanso dongosolo lolimba la thanzi labwino ndi chitetezo (EHS).

JXBio yadutsa kuwunika kwa GMP kochitidwa ndi US FDA ndi NMPA yaku China, ndipo yadziwika ndi makampani opanga mankhwala padziko lonse lapansi chifukwa chakuchita bwino pa kayendetsedwe ka EHS - umboni wakudzipereka kwathu pazabwino, chitetezo, komanso kusamalira zachilengedwe.
Magawo a Bizinesi Yapakati
• Kulembetsa kwapadziko lonse ndikutsata ma peptide API
• Chowona Zanyama ndi zodzikongoletsera peptides
• Ntchito zama peptide (CRO, CMO, OEM)
• Peptide-drug conjugates (PDCs), kuphatikizapo:
• Peptide-radionuclide
• Peptide - molekyulu yaying'ono
• Peptide-mapuloteni
• Peptide-RNA Therapeutics

ZOPHUNZITSA ZABWINO

Kuti mumve zambiri pazogulitsa zathu, lemberani.
Mafunso a Global API ndi Zodzikongoletsera: Tel No.: +86-15013529272;
Kulembetsa kwa API & Ntchito za CDMO (msika wa USA EU): +86-15818682250
E-mail: jymed@jymedtech.com
Address: Pansi 8 & 9, Building 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen